Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Synovial sarcoma

C Fisher1

  • 1Royal Marsden NHS Trust, London, UK.

Annals of Diagnostic Pathology
|February 4, 1999
PubMed
Summary
This summary is machine-generated.

Synovial sarcoma, a rare soft tissue tumor, presents diverse forms and specific genetic markers. Recent advances improve local control, but managing metastases remains challenging.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

N-terminal pro B type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure.

Heart (British Cardiac Society)·2003
Same author

Transcardiac and transpulmonary gradients in the putative new cardiovascular hormone relaxin.

Heart (British Cardiac Society)·2003
Same author

Calponin and h-caldesmon expression in synovial sarcoma; the use of calponin in diagnosis.

Histopathology·2003
Same author

Tumour thickness predicts cervical nodal metastases and survival in early oral tongue cancer.

Oral oncology·2003
Same author

Hb Q-India: an uncommon variant diagnosed in three Punjabi patients with diabetes is identified by a novel DNA analysis test.

Journal of clinical pathology·2003
Same author

Imaging features of aggressive angiomyxoma.

Clinical radiology·2003
Same journal

Unusual morphologic features in molecularly defined high-grade sarcomas of the uterus.

Annals of diagnostic pathology·2026
Same journal

Clinicopathologic features and prognostic factors in hepatic epithelioid hemangioendothelioma.

Annals of diagnostic pathology·2026
Same journal

Analysis of SOX2 and SOX17 expression in cervical HPV-associated adenocarcinoma in situ: Correlation with histologic variants.

Annals of diagnostic pathology·2026
Same journal

Challenges and limitations in the pathological application of the ISSVA 2025 classification of vascular anomalies: A 5-year retrospective study.

Annals of diagnostic pathology·2026
Same journal

The utility of clonal relatedness molecular testing in cytology: An institutional experience.

Annals of diagnostic pathology·2026
Same journal

Russell body gastritis: a clinicopathological analysis of five cases and literature review.

Annals of diagnostic pathology·2026
See all related articles

Area of Science:

  • Oncology
  • Pathology
  • Genetics

Background:

  • Synovial sarcoma is a rare soft tissue neoplasm affecting both children and adults, originating in various body locations.
  • It is characterized by biphasic or monophasic forms, exhibiting epithelial or spindle cell differentiation.
  • Recognized subtypes include myxoid, hemangiopericytic, calcifying, ossifying, and poorly differentiated patterns.

Observation:

  • Immunohistochemical analysis reveals common reactivity for cytokeratin, epithelial membrane antigen, and bc12 protein, with frequent S100 protein and CD99 expression.
  • A hallmark genetic feature is the specific chromosomal translocation t(x;18)(p11.2;q11.2), leading to SYT-SSX gene fusions.
  • Differential diagnosis involves distinguishing it from other sarcomas with similar cellular morphologies.

Findings:

Related Experiment Videos

  • The specific genetic alterations in synovial sarcoma are linked to its diverse morphology and clinical behavior.
  • Immunohistochemical profiles aid in identifying epithelial differentiation, crucial for diagnosis.
  • The translocation t(x;18) is a highly specific diagnostic marker for synovial sarcoma.

Implications:

  • Understanding the genetic basis and diverse presentations of synovial sarcoma is key for accurate diagnosis and treatment.
  • Improved diagnostic markers and therapeutic strategies are needed to enhance patient outcomes.
  • Further research into the molecular mechanisms driving synovial sarcoma can lead to targeted therapies.